"Methods And Compositions For Screening And Treating Alzheimer'S Disease" in Patent Application Approval Process (USPTO 20240310389).

This patent application presents methods and compositions for screening and treating Alzheimer's Disease (AD). The inventors suggest that genetic variants and urea cycle disorders may play a role in the development of AD. They propose administering urea cycle agents to individuals with AD or at risk of developing AD, based on specific genetic variations. The application provides a list of urea cycle agents and genetic variations that may be used in these methods. [Extracted from the article]